Mon.Jun 10, 2024

article thumbnail

3 AI Imaging Advances for Skin Cancer Detection & Tracking

MedEsthetics

93% of readers are interested in novel advances in AI imaging for skin cancer detection and tracking! Here are three AI imaging advances for skin cancer detection and tracking.

146
146
article thumbnail

La Roche-Posay UVMune 400: Science and Review

Lab Muffin Beauty Science

The La Roche-Posay UVMune 400 range has been super hyped up because it contains a brand new sunscreen ingredient: Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (MCE), or Mexoryl 400. It’s currently exclusive to L’Oreal, and was developed in conjunction with BASF. I’ve mentioned in passing that I don’t think it’s as much of a game changing “must have” for everyone that some people have.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Comparing AD Guidelines From Around the World

Dermatology Times

Robert Sidbury, MD, MPH, addresses the similarities and differences between the AAD’s recent atopic dermatitis guidelines and other guidelines from various groups and countries.

article thumbnail

Orange County, CA – Sept. 27 – Fractional Laser Skin Resurfacing Course

AAFE - American Academy of Facial Esthetics

If you have a tuition voucher from a laser company, please call 800.952.0521 to register for this course.

78
article thumbnail

Looking Ahead to Advancements in Vitiligo and Atopic Dermatitis

Dermatology Times

David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.

article thumbnail

Greek Yogurt Chicken Salad

Alison Bladh

Greek Yogurt Chicken Salad Looking for a light yet satisfying lunch option? This Greek Yogurt Chicken Salad is the perfect blend of creamy and crunchy, packed with protein. It’s an excellent choice for those wanting a nutritious meal without the heaviness. Plus, it’s easy to prepare Ingredients • 2 cups (480 ml) cooked chicken breast, shredded • 1/2 cup (120 ml) Greek yogurt • 1/4 cup (60 ml) mayonnaise (optional for extra creaminess) • 1/2 cup (120 ml) celery, finely chopped • 1/2 cup (120 ml)

More Trending

article thumbnail

What Are the Benefits of Adding PRP to Microneedling?

Natural Beauty Med Spa

Would you like to achieve a smoother, brighter, and more even complexion? Microneedling is a minimally invasive treatment that may be able to help you reach those goals. It is a wonderful cosmetic option on its own, but did you know that it is even better when it is used alongside PRP? What is microneedling with PRP , and what benefits does it offer?

article thumbnail

Addressing Itch and Remission in Atopic Dermatitis

Dermatology Times

Raj Chovatiya, MD, PhD, discusses how approved AD therapeutics currently address itch and whether any therapeutics will eventually have a remittive effect.

article thumbnail

The Ultimate Lash + Brow Profit Guide from elleebana

Lipgloss and Aftershave

The Ultimate Lash + Brow Profit Guide from elleebana Elevate your salon revenue with the Elleebana Aftercare range! Discover the exclusive allure of the house of Elleebana and boost your salon’s success with our luxurious aftercare collection.

article thumbnail

FDA Approves Expanded Use of Tirbanibulin for Actinic Keratosis

Dermatology Times

Phase 3 clinical results showed that the safety and tolerability profiles were consistent with those observed in the original pivotal trials.

Safety 74
article thumbnail

Medical + spa skincare professionals can spend July + August expanding their science skill set

Spa Industry Association

L+A has created an 8 W eek Summer School Course that includes exclusive access to 13 Webinars and 7 Downloadable Guides / E-books. L+A Summer School is free! This course includes exclusive access to thirteen webinars and seven downloadable guides or ebooks. It’s a fantastic opportunity to invest in yourself through ongoing education. Register once and you’ll receive updates on all the classes and replays.

Webinar 40
article thumbnail

Day 2 Recap: 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference

Dermatology Times

Catch up on coverage from the last day of the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference in Chicago, Illinois.

Eczema 74
article thumbnail

3 Part Non-Surgical, Non-Invasive Treatment to Firm, Plump + Glow 

Lipgloss and Aftershave

You may think it’s too good to be true that a non-surgical treatment that is non-invasive can provide firmness to skin laxity, boost the skin volume, and give it a luminescent glow until you learn about Sesha’s combination of sophisticated ingredients and their P.E.T® Technology Delivery System! Thanks to Sesha for sponsoring this content so that we can educate the L+A community on this incredible treatment.

article thumbnail

MoonLake Immunotherapeutics Announces FDA, EMA Support of Furthering Phase 3 Sonelokimab for PsA

Dermatology Times

The phase 3 IZAR program will evaluate the efficacy and safety of sonelokimab in patients with psoriatic arthritis for a 1 year duration.

Safety 74
article thumbnail

U.S. Dermatology Partners Stillwater Relocates to Expanded Office Space

US Dermatologt Partners

Stillwater, Oklahoma – U.S. Dermatology Partners is pleased to announce the relocation of its Stillwater, Oklahoma , location to a new, expanded office space. U.S. Dermatology Partners Stillwater Announces their Relocation into a New Expanded Office Space The expanded office is located at 1212 W. 12 th Avenue in Stillwater, Oklahoma , and will open on June 10, 2024.

Office 41
article thumbnail

Exploring New Pathways in Atopic Dermatitis

Dermatology Times

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.

article thumbnail

Rare Skin Disease Treatment Update: Transplanting Genetically Healthy Skin to Inflamed Areas May Help Treat EI and IWC

The Dermatology Digest

Transplanting healthy skin to diseased areas may be treatment option for epidermolytic ichthyosis (EI) and ichthyosis with confetti (IWC), according to a study out of Nagoya University Graduate School of Medicine in Japan. The researchers found that revertant somatic recombination could be used for a pioneering therapy. By making grafts called cultured epidermal autografts (CEAs), which contain genetic mutation corrections that give healthy skin, and grafting these naturally corrected skin cells

article thumbnail

Late-Breaker: Upadacitinib Demonstrates Superiority Over Dupilumab in All Ranked Secondary End Points of Head-to-Head AD Study

Dermatology Times

The phase 3b/4 LEVEL-UP study assessed adolescents and adults with moderate to severe atopic dermatitis.

article thumbnail

MoonLake Immunotherapeutics Receives Regulatory Greenlights for Phase 3 Program of Sonelokimab in PsA

The Dermatology Digest

MoonLake Immunotherapeutics received positive feedback from the U.S. Food and Drug Administration (FDA) and the E.U. European Medicines Agency (EMA) on its Phase 3 Program for the nanobody sonelokimab in Psoriatic Arthritis (PsA). Sonelokimab (M1095) is an investigational ~40 kDa humanized nanobody consisting of three VHH domains covalently linked by flexible glycine-serine spacers.

Office 36
article thumbnail

Promising Results in Phase 2 Trial of ProSilic

Dermatology Times

The trial reported complete hair regrowth for a number of participants, with 76% of a partial cohort meeting the primary endpoint of 30% improvement.

57
article thumbnail

FDA Approves Almirall’s Klisyri for the Treatment of AKs on Expanded Area of Face or Scalp up to 100 cm2

The Dermatology Digest

The U.S. Food and Drug Administration (FDA) approved Almirall’s recent supplemental New Drug Application (sNDA) to expand the use area of tirbanibulin ( Klisyri) for the treatment of actinic keratosis (AK) on the face or scalp up to 100 cm 2. Klisyri, a microtubule inhibitor ointment, is now approved in a 350 mg package size and is a 5-day topical field treatment for actinic keratosis (AK) of the face or scalp.

article thumbnail

Late-Breaker: Roflumilast Cream 0.15% Demonstrates Continued Improvement in AD Symptoms Through 56 Weeks

Dermatology Times

Roflumilast cream 0.15% is being evaluated for patients with mild to moderate atopic dermatitis down to 6 years.

article thumbnail

Ask The Esty: Top Questions to Ask Before Treating Acne

Skin Inc

acne treatment, acne education, acne treatments, acne products, spa business, spa business tips, acne business, spa owner

article thumbnail

Optimizing Long-Term Care: Physician Insights on Secondary Dermatitis Management

Dermatology Times

Kristine Kucera, PA-C, MPAS, DHS, discusses prescribing a PDE-4 inhibitor for Mickey Bryson's psoriasis and atopic dermatitis, emphasizing the absence of FDA-approved medications like JAK inhibitors, while Bryson underscores the challenges of daily injections, likening it to insulin use.

article thumbnail

Meet Sandrelly Soto: Beauty Launchpad 30 Over 30 Winner for 2024

Beauty Launchpad

Get to know Sandrelly Soto (@lelystyles). She is a hairstylist at Theory Salon Mills 50 in Orlando, FL.

Salon 40
article thumbnail

Atopic Dermatitis vs. Contact Dermatitis: What’s the Difference?

First Derm

Online Dermatologist Atopic Dermatitis vs. Contact Dermatitis: What’s the Difference? Atopic dermatitis (left) and contact dermatitis (right) display different symptoms. Atopic dermatitis features red, inflamed patches with small bumps, while contact dermatitis shows a red, inflamed area with crusting and defined borders What is Dermatitis | Similarities | Differences | Triggers | Causes | Diagnosis | Treatment Options | How to Prevent and Monitor the Progression Key Takeaways Atopic Dermatitis

article thumbnail

Behind the Headlines: Here’s What to Know About the First U.S. Case of Sexually Transmitted TMVII

The Dermatology Digest

Avrom Caplan, MD, an Assistant Professor in the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine in New York City, shares details on the first reported U.S. case of a sexually transmitted form of ringworm caused by Trichophyton mentagrophytes type VII (TMVII) in a man in his 30s who developed the rash on his penis, buttocks, and limbs after returning home to New York City from a trip to England, Greece, and California.